FDA Publishes Revised Draft Guidances for Generic Peptide Products

The U.S. Food and Drug Administration (FDA) has published 17 revised draft product-specific guidances (PSGs) for peptide products. This action marks a significant step in the agency's scientific and regulatory approach to assessing generic peptide drugs. The guidances address various peptide products, including Calcitonin salmon and Glucagon.